CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病预防

科研文章

荐读文献

Negative Risk Markers for Cardiovascular Events in the Elderly Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

Review Article2021 Mar 16;143(11):1157-1172.

JOURNAL:Circulation. Article Link

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options

J Jankowski, J Floege, D Fliser et al. Keywords: chronic kidney disease; cardiovascular disease; pathophysiology; therapy

Full Text PDF